Description
SC-560 is an orally active and highly selective cyclooxygenase-1 (COX-1) inhibitor with IC50= 0.009 µM for COX-1, and 6.3 µM for COX-2. SC-560 also significantly reduces ovarian surface epithelial tumor growth in vivo by causing cell cycle arrest at the G1 phase